44 results on '"Asseburg, Christian"'
Search Results
2. Macrovascular Risk Equations Based on the CANVAS Program
3. Risk-stratified analysis of long-term clinical outcomes and cumulative costs in Finnish patients with recent acute coronary syndrome or coronary revascularization: a 5-year real-world study using electronic health records.
4. Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge
5. Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial Data
6. Conducting and interpreting results of network meta-analyses in type 2 diabetes mellitus: A review of network meta-analyses that include sodium glucose co-transporter 2 inhibitors
7. Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge
8. Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature Review
9. A Bayesian approach to modelling field data on multi-species predator prey-interactions
10. Multivariate Prediction Equations for HbA1c Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus: Informing Economic Modeling
11. Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients with Moderate-to-Severe Rheumatoid Arthritis in Finland
12. Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)
13. Cost effectiveness of golimumab for the treatment of active psoriatic arthritis
14. The Cost-Effectiveness of Different Chemotherapy Strategies for Patients with Poor Prognosis Advanced Colorectal Cancer (MRC FOCUS)
15. Cost-effectiveness of infliximab for the treatment of active and progressive psoriatic arthritis
16. Cost-Effectiveness of Targeted Therapy With Cetuximab in Patients With K- ras Wild-Type Colorectal Cancer Presenting With Initially Unresectable Metastases Limited to the Liver in a German Setting
17. Sensitivity to Assumptions in Models of Generalist Predation on a Cyclic Prey
18. Preventive Strategies for Group B Streptococcal and Other Bacterial Infections in Early Infancy: Cost Effectiveness and Value of Information Analyses
19. Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge
20. Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation
21. Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
22. sj-docx-1-mdm-10.1177_0272989X211065479 ��� Supplemental material for Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge
23. Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation
24. Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge.
25. Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty project
26. Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis
27. Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis
28. Why Threshold Target Performance-Based Metrics May Not Improve Population Health as Much as Treatment Pathways
29. Erratum to: Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
30. Assessing the Value of Canagliflozin (CANA) vs. Sitagliptin (SITA) as Second-Line Therapy in the U.S.—The Importance of Considering Evidence from the CANVAS Program
31. Multivariate Prediction Equations for HbA 1c Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus: Informing Economic Modeling
32. Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)
33. Vilken betydelse har hälsoekonomi vid prioriteringar? : ett experiment bland beslutsfattare och en analys avfaktiska prioriteringar
34. Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data
35. Validation of economic and health outcomes simulation model of type 2 diabetes mellitus (ECHO-T2DM)
36. COST-EFFECTIVENESS OF ORAL TRIPTANS FOR ACUTE MIGRAINE: MIXED TREATMENT COMPARISON
37. Effectiveness and Cost-Effectiveness of Antidepressants in Primary Care: A Multiple Treatment Comparison Meta-Analysis and Cost-Effectiveness Model
38. Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection
39. Cost effectiveness of golimumab for the treatment of active psoriatic arthritis
40. Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial
41. The Functional Response of a Generalist Predator
42. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses.
43. [Indirect comparison and network meta-analyses--new tools for the assessment of evidence on the relative efficacy of drugs].
44. Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.